ARCHIVES

Cyramza-Docetaxel Combination Extends OS In Second-Line NSCLC

This article is from The Cancer Letter archive.

Vol. 37 No. 6 | June 27, 2014

Download PDF Visit The Full Archive

Related Articles

Stereotactic Body Radiotherapy Could Improve Overall Survival

July 29, 2011

In Brief: Mansfield To Head NCI Radiation Research; Cowan Is Acting Chief, Medicine Branch

June 23, 1995

Piedmont, Mid-Atlantic Organizations Win Competition for NCI Support Of New Regional Cooperative Groups

April 16, 1982

Cancer Death Rates Improving, But Still Higher, In Blacks

February 23, 2007

No Evidence Of Fraud Found In NCI Audit Of NSABP Trials

April 29, 1994

FDA Discloses Responses, Toxicities For Burzynski’s “Antineoplastons”

April 24, 1998